Lesage Anne sold $81K of PHVS (indirect holdings)
Lesage Anne (Chief Early Development) sold 2,300 indirectly-held shares of Pharvaris N.V. (PHVS) at $35.12 on 2026-06-25 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The newest fact is the specific open-market sale details (2,300 shares at $35.1242) and that it was executed under a pre-arranged 10b5-1 plan.
Market read
This provides incremental transparency on insider activity but does not introduce new fundamentals, guidance, or regulatory/clinical catalysts.
What to watch
Indirect holdings and 10b5-1 structure can obscure true discretion; the modest size ($80.8K) limits interpretive power versus larger, non-10b5-1 transactions.
Background
The article is an SEC Form 4 insider transaction disclosure for Pharvaris N.V. (PHVS).
Ticker impact
SEC Form 4 shows officer Lesage Anne sold 2,300 PHVS shares on 2026-06-25 under a 10b5-1 plan, totaling ~$80.8K.
Low likelihood of sustained price impact; any reaction should be muted unless accompanied by other company-specific catalysts.
The filing is a disclosed open-market sale with a pre-arranged 10b5-1 plan and modest dollar value, which typically reduces interpretive weight versus discretionary selling.
Market effects
No sector read-through; this is a single-company insider transaction.
None indicated.
None indicated.
Counterpoint
Even with 10b5-1, repeated insider selling can coincide with periods of reduced conviction; traders may still monitor for a pattern across filings.
Key entities
- issuerPHVS
Pharvaris N.V., the company whose insider transaction is disclosed.
- insiderLesage Anne
Chief Early Development; reported an open-market sale of PHVS shares via indirect holdings.
